When hemp got freed up federally, Bud saw his long-held dream materialize - finally he could cultivate this misunderstood historian plant pioneered by the...
A recent survey indicates a growing optimism among institutional investors towards U.S. cannabis multistate operators (MSOs). The key driver behind this heightened sentiment is...
Certain cannabis industry leaders are optimistic that the federal government's reclassification of marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act...
From fervent anti-drug crusader to disconnected senior statesman to the unlikely champion of the regulated marijuana trade, President Joe Biden's public journey might still...
An individually tailored cannabis regimen may ease symptoms of autism, according to an August study published by Frontiers in Psychiatry. The researchers studied 20...
The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of...
MDMA doesn’t have the best reputation. Known as “ecstasy” or “molly,” the drug is synonymous with rave culture: all-night electronic beats and choreographed laser...
